# Luye Pharma Group Ltd. (LYPHF)

> Healthcare · CN · Reports in CNY

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/LYPHF/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | ¥ 6.26B | ¥ 613.67M | ¥ 2.20B | ¥ 9.42B | ¥ 16.08B |
| 2024 | ¥ 6.09B | ¥ 474.17M | ¥ -1.55B | ¥ 10.32B | ¥ 14.15B |
| 2023 | ¥ 6.18B | ¥ 535.71M | ¥ -126.34M | ¥ 8.42B | ¥ 12.53B |
| 2022 | ¥ 6.00B | ¥ 606.56M | ¥ 1.00B | ¥ 9.10B | ¥ 10.18B |
| 2021 | ¥ 5.31B | ¥ -137.17M | ¥ -381.57M | ¥ 9.49B | ¥ 8.49B |
| 2020 | ¥ 5.74B | ¥ 731.61M | ¥ 352.70M | ¥ 9.98B | ¥ 7.89B |
| 2019 | ¥ 6.60B | ¥ 1.45B | ¥ 439.47M | ¥ 8.07B | ¥ 9.22B |
| 2018 | ¥ 5.61B | ¥ 1.41B | ¥ 344.10M | ¥ 6.14B | ¥ 7.81B |
| 2017 | ¥ 4.21B | ¥ 1.08B | ¥ 504.64M | ¥ 2.86B | ¥ 6.77B |
| 2016 | ¥ 3.28B | ¥ 1.00B | ¥ 369.77M | ¥ 1.62B | ¥ 6.43B |
| 2015 | ¥ 2.94B | ¥ 865.90M | ¥ 109.37M | ¥ 502.72M | ¥ 5.66B |
| 2014 | ¥ 2.97B | ¥ 706.14M | ¥ 263.24M | ¥ 305.54M | ¥ 4.91B |
| 2013 | ¥ 2.97B | ¥ 367.19M | ¥ 205.30M | ¥ 745.31M | ¥ 1.77B |
| 2012 | ¥ 2.59B | ¥ 204.91M | ¥ 8.08M | ¥ 0 | ¥ 1.46B |
| 2011 | ¥ 2.10B | ¥ 166.24M | ¥ -16.42M | ¥ 455.82M | ¥ 1.28B |
| 2010 | ¥ 1.73B | ¥ 175.98M | ¥ 159.13M | ¥ 265.46M | ¥ 1.13B |
| 2009 | ¥ 686.28M | ¥ 78.66M | ¥ 49.40M | ¥ 200.69M | ¥ 987.30M |
| 2008 | ¥ 895.17M | ¥ 85.38M | ¥ 84.76M | ¥ 140.77M | ¥ 821.29M |
| 2007 | ¥ 708.73M | ¥ 82.13M | ¥ 173.43M | ¥ 253.06M | ¥ 775.93M |
| 2006 | ¥ 457.53M | ¥ 120.08M | ¥ 61.77M | ¥ 28.93M | ¥ 727.56M |
| 2005 | ¥ 525.43M | ¥ 137.57M | ¥ 20.55M | ¥ 10.74M | ¥ 345.03M |
| 2004 | ¥ 488.84M | ¥ 111.34M | ¥ 56.59M | ¥ 57.00M | ¥ 272.09M |
| 2003 | ¥ 377.50M | ¥ 67.51M | ¥ 43.05M | ¥ 125.01M | ¥ 96.29M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.59 |
| Liabilities / Eq | 0.88 |
| Current Ratio | 1.53 |

## Debt coverage

| Indicator | Value |
| --- | --- |
| Gross Debt / Earnings | 12.12 |
| Gross Debt / FCF | 29.89 |

## Other views

- [Metrics](https://sponda.capital/en/LYPHF.md)
- [Charts](https://sponda.capital/en/LYPHF/charts.md)
- [Compare](https://sponda.capital/en/LYPHF/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.